INVESTMENT IN AMAK AND DISCONTINUED OPERATIONS - Equity in the Income or Loss of Equity Method Investment (Details) - AMAK - USD ($) $ in Thousands |
9 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Schedule of Equity Method Investments [Line Items] | |||
| AMAK Net Income (Loss) | $ (127) | $ (7,010) | $ (6,729) |
| Company's share of income (loss) reported by AMAK | (308) | (1,996) | (2,248) |
| Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK | 1,010 | 1,010 | 1,347 |
| Equity in earnings (losses) of AMAK | $ 702 | $ (986) | $ (901) |
| X | ||||||||||
- Definition The amount of net income (loss) reported by an equity method investment of the entity after tax. No definition available.
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This amount is prior to any amortizations or costs allocated to the investee. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|